Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 62, 2002 - Issue 5
Submit an article Journal homepage
99
Views
82
CrossRef citations to date
0
Altmetric
Research Article

Butyrylcholinesterase activity and risk factors for coronary artery disease

V. M. Alcântara Departments of Medical Pathology; Genetics and Clinical Medicine, Federal University of Parana, Curitiba, PR, Brazil
,
E. A. Chautard-Freire-Maia Departments of Medical Pathology; Genetics and Clinical Medicine, Federal University of Parana, Curitiba, PR, Brazil
,
M. Scartezini Departments of Medical Pathology; Genetics and Clinical Medicine, Federal University of Parana, Curitiba, PR, Brazil
,
M. S. J. Cerci Departments of Medical Pathology; Genetics and Clinical Medicine, Federal University of Parana, Curitiba, PR, Brazil
,
K. Braun-Prado Departments of Medical Pathology; Genetics and Clinical Medicine, Federal University of Parana, Curitiba, PR, Brazil
&
G. Picheth Departments of Medical Pathology; Genetics and Clinical Medicine, Federal University of Parana, Curitiba, PR, Brazil
Pages 399-404 | Published online: 08 Jul 2009

  • McNamara JR, Warnick GR, Wu LL. Lipids and lipoproteins. In: Bishop ML, Duben-Engelkirk JL, Fody EP, editors. Clinical Chemistry: principles, procedures, correlations. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2000.
  • Albers JJ, Brunzell JD, Knopp RH. Apoprotein measurements and their clinical application. Clin Lab Med 1989; 9:137-52.
  • Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983; 67:730-4.
  • De Backer G, Rosseneu M, Deslypere JP. Discriminative value of lipids and apoproteins in coronary heart disease. Atherosclerosis 1982; 42:197-203.
  • Chautard-Freire-Maia EA, Primo-Parmo SL, Picheth G, Lourenço MA, Vieira MM. The isozyme C5 of serum cholinesterase and adult weight. Hum Hered 1991; 41:330-9.
  • Whittaker M. Cholinesterase. New York, Basel: Karger; 1986.
  • Clitherow JW, Mitchard M, Harper NJ. The possible biological function of pseudocholinesterase. Nature 1963; 199:1000-1.
  • Cucuianu M, Popescu TA, Haragus S. Pseudocholinesterase in obese and hyperlipemic subjects. Clin Chim Acta 1968; 22:151-5.
  • Kutty KM, Rowden G, Cox AR. Interrelationship between serum R-lipoprotein and cholinesterase. Can J Biochem 1973; 51:883-7.
  • Magadan EO, Dietz AJ. Correlation of cholinesterase with serum lipids and lipoproteins. J Clin Pharmacol 1987; 27:819-20.
  • Cucuianu M, Popescu TA, Opincaru A, Haragus S. Serum pseudocholinesterase and ceruloplasmin in various types of hyperlipoproteinemia. Clin Chim Acta 1975; 59:19-27.
  • Crook M, Haq M, Tutt P. Serum lipids, acute phase proteins and serum cholinesterase in normal subjects. Scand J Clin Lab Invest 1994; 54:601-3.
  • Alcântara VM. Fenótipos da butirilcolinesterase e suas relações com dados antropometricos, bioquimico-hormonais e pressão arterial em obesos e na população gerai de Curitiba, PR. D. Sc. Thesis, Federal University of Paraná, Curitiba, Brazil, 2000.
  • Chu MI, Fontaine P, Kutty KM, Murphy D, Redheendran R. Cholinesterase in serum and low density lipoprotein of hyperlipidaemic patients. Clin Chim Acta 1978; 22:151-5.
  • Kutty KM, Jain R, Huang S, Kean K. Serum pseudocholinesterase: high density lipoprotein cholesterol ratio as an index of risk for cardiovascular disease. Clin Chim Acta 1981; 115:55-61.
  • Lehtonen A, Marniemi J, Inberg M, Maatela J, Alanen E, Niittymäki K. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation. Atherosclerosis 1986; 59:215-21.
  • Dietz AA, Rubinstein HM, Lubrano T. Colorimetric determination of serum cholinesterase and its genetic variant s by the propionylthiocholine-dithiobis (nitrobenzoic acid) procedure. Clin Chem 1973; 19:1309-13.
  • Evans RT, Wroe J. Is serum cholinesterase activity a predictor of succinylcholine sensitivity? An assessment of four methods. Clin Chem 1978; 24:1762-66.
  • Alcântara VM, Chautard-Freire-Mai a EA, Picheth G, Vieira MM. Method for serum cholinesterase phenotyping. Rev Bras Genet 1991; 14:841-6.
  • Picheth G, Fadel-Picheth C, Primo-Parmo SL, Chautard-Freire-Maia EA, Vieira MM. An improved method for butyrylcholinesterase phenotyping. Biochem Genet 1994; 32:83-9.
  • Van Ros G, Vervoort T. Frequencies of the atypical and C5 variants of serum cholinesterase in Zairians and Belgians. Detection of the C5 variant by agar gel electrophoresis with an acid buffer. Ann Soc BeIg Méd Trop 1973; 53:633-44.
  • Statsoft, Inc. 1996. STATISTICA for Windows. Tulsa, OK. Release S.I: http://www.statsoftinc.com.
  • Chautard-Freire-Maia EA, Primo-Parmo SL, Canever de Lourenco MA, Culpi L. Frequencies of atypical serum cholinesterase among Caucasians and Negroes from Southern Brazil. Hum Hered 1984; 34:388-92.
  • Alcântara VM, Chautard-Freire-Maia EA, Culpi L. CHEl UF serum cholinesterase phenotype in Whites and non-Whites from Southern Brazil as determined by a new method. Hum Hered 1991; 41:103-6.
  • Antopol W, Tuchman T, Schifrin W. Cholineesterase activity in human serum with special reference to hyperthyroidism. Proc Soc Exp Biol Med 1937; 36:46-9.
  • Reinfrank RF, Wetstone HJ. Serum cholinesterase activity in hypertension: report of a pilot study. Hartford Hosp Bull 1958; 13: 32.
  • Berry WTC, Cowin PJ, Davies DR. A relationship between body fat and plasma pseudocholinesterase. Br J Nutr 1954; 8:79-82.
  • Brock A, Brock V. Plasma cholinesterase activity in a healthy population group with no occupational exposure to known cholinesterase inhibitors: relative influence of some factors related to normal inter- and intra-individual variations. Scand J Clin Lab Invest 1990; 50:401-8.
  • Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987; 28:613-28.
  • Pavkovic E, Simeon V, Reiner E, Sucic M, Lipovac V. Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders. Chem Biol Interact 1993; 87:179-82.
  • Jain R, Kutty KM, Huang SN, Kean K. Pseudocholinesterase/high-density lipoprotein cholesterol ratio in serum of normal persons and of hyperlipoproteinemics, Clin Chem 1983; 29:1031-3.
  • Kutty KM, Payne RH. Serum pseudocholinesterase and very-low-density lipoprotein metabolism. J Clin Lab Anal 1994; 8:247-50.
  • Abbott CA, Mackness MI, Kumar S, Olukoga AO, Gordon C, Arrol S, Bhatnagar D, Boulton AJ, Durrington PN. Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus. Clin Sei 1993; 85:77-81.
  • Oreskovic K, Kunec-Vajic E. Pseudocholinesterase in alloxan-diabetic rats. Res Commun Chem Pathol Pharmacol 1992; 78:117-20.
  • Popovic L, Oreskovic K, Zupancic B, Petrunic M, Kunec-Vajic E. The relation between plasma lipid levels and pseudocholinesterase activity in hypothyroidism. Horm Metab Res 1998; 30:137-40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.